According to data and analytics company Global Data, in 2020 the market for global neuropathic pain will amount to $10.2 billion. Currently, it is forecasted to grow at a CAGR of 12.5% to reach 25 billion by 2027. This signifies the huge need for treatment. $HEM is constantly working to supply the treatment-based element of ACP-01.
